ENDRA Life Sciences Financials - Benzinga

ENDRA Life Sciences Inc

NDRANASDAQ

Trade with Public

Trade with Public

$5.68

-0.78-12.07%

At close: Sep 3, 5:00 PM EST

$6.40

0.7212.68%

After Hours: Sep 2, 5:32 PM EST

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare Stock Report

ENDRA Life Sciences Financials

ENDRA Life Sciences (NDRA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
ENDRA Life Sciences Q2 EPS $0.06 Beats $(0.84) Estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.84) by 107.14 percent. This is a 103.51 percent increase over losses of $(1.71) per share

Benzinga Newsdesk

PRO
ENDRA Life Sciences Q1 EPS $(1.09) Beats $(1.14) Estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.14) by 4.39 percent. This is a 41.4 percent increase over losses of $(1.86) per share from

Benzinga Newsdesk

PRO
ENDRA Life Sciences Q4 EPS $(3.25) Misses $(1.95) Estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(3.25) per share which missed the analyst consensus estimate of $(1.95) by 66.67 percent. This is a 55.78 percent increase over losses of $(7.35) per share

Benzinga Newsdesk

PRO
ENDRA Life Sciences Q3 EPS $(2.10) Misses $(1.95) Estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(2.10) per share which missed the analyst consensus estimate of $(1.95) by 7.69 percent. This is a 77.99 percent increase over losses of $(9.54) per share

Benzinga Newsdesk

PRO
ENDRA Life Sciences Q2 EPS $(1.71) Beats $(2.27) Estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.71) per share which beat the analyst consensus estimate of $(2.27) by 24.67 percent. This is a 2037.5 percent decrease over losses of $(0.08) per share

Benzinga Newsdesk

PRO
ENDRA Life Sciences Expects Q2 2025 Loss Of ~$1.3M, No Revenue, And ~$2.6M In Total Assets

Recent Financial ResultsBelow is a summary of certain preliminary estimates regarding our financial results for the quarter ended June 30, 2025. This preliminary financial information is based upon our estimates and is

Benzinga Newsdesk